NEWTON, MA – Nov. 19, 2021 – Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and …
News
Kent Imaging – Setting A New Global Standard in Advanced Tissue Assessment
November 16, 2021 Kent Imaging is a market leader in light-based tissue assessment diagnostic devices. The company designs and manufactures imaging technology that supports real-time …
Nekonal and TVM Capital Life Science Announce Creation of T7 Therapeutics to Develop Innovative Therapy for Patients with Auto-immune diseases
Luxembourg, November 15th, 2021 – TVM Life Science Innovation II SCSp announced the Fund's investment establishing T7 Therapeutics, Inc., a company based in Wilmington, Delaware, USA. T7 …
CENTOGENE and Twist Bioscience to Develop Advanced Sequencing Tools to Make Genetic Testing Rapidly Accessible for More Patients With Rare Diseases
Combining Expertise to Advance Precision Medicine, While Enabling a More Efficient and Timely Diagnosis of Rare Diseases Around the World CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN and SOUTH …
Acer Therapeutics Receives Notice of Allowance of Key U.S. Patent Application Covering ACER-001 Formulation
Notice of allowance of ACER-001 formulation composition of matter patent application strengthens proprietary position in U.S. until 2036 NEWTON, MA and GENEVA, SWITZERLAND – October 7, 2021 – Acer …
Rapid Micro Biosystems Announces Pricing of Initial Public Offering
Source: Rapid Micro Biosystems, Inc.July 14, 2021 21:30 ETLOWELL, Mass., July 14, 2021 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (“RapidMicro”), an innovative life sciences …